This invention provides novel peptides that ameliorate one or more symptoms
of atherosclerosis and/or other pathologies characterized by an inflammatory response.
In certain embodiment, the peptides resemble a G* amphipathic helix of apolipoprotein
J. The peptides are highly stable and readily administered via an oral route.